For Targeting Cancer Therapy Articles & Analysis: Older
194 articles found
They are adept at identifying and destroying infected or cancerous cells. However, their natural capacity may not always be sufficient to combat complex diseases. ...
This initiative represents a critical advancement in pursuing effective bladder cancer therapies and underscores the company’s commitment to providing diverse high-quality services for various fields of cancer research. ...
In recent years, messenger RNA (mRNA) technology has emerged as a revolutionary approach in the field of medicine, particularly in vaccine development and gene therapy. The ability to deliver mRNA effectively to target cells is crucial for harnessing its potential in treating a variety of diseases, including infectious diseases, cancer, and ...
This mimetic action allows researchers to enhance or restore the expression of target genes that are otherwise downregulated in diseases such as cancer, neurodegenerative disorders, and cardiovascular diseases. ...
They are utilized as active pharmaceutical ingredients (APIs) due to their specificity and efficacy. Pharmaceutical peptide can target receptors with high precision, minimizing off-target effects and enhancing therapeutic action. Notable examples include peptide hormones like insulin and drugs used in cancer treatment. Vaccines Synthetic ...
But the applications of mRNA extend far beyond vaccines: Cancer Treatment: Enzymes facilitate the development of mRNA-based therapies. ...
To date, scientists have leveraged various therapeutic avenues, including precision medicine, targeted therapies, and immunotherapy. However, issues such as drug delivery across the blood-brain barrier, tumor heterogeneity, and therapeutic resistance remain unresolved. Therefore, comprehensive drug development is pivotal in addressing these challenges and ...
Cancer is a worldwide disease and one of the leading causes of morbidity and mortality today. ...
Precision-Cut Lung Slices (PCLS) have emerged as a innovative ex vivo model that allows researchers to explore deep into lung physiology, disease mechanisms, and pharmacological responses. By offering a unique combination of biological complexity and controlled experimental conditions, PCLS serve as a critical bridge between the limitations of traditional in vitro cell cultures and the ...
It involves the delivery of new genetic molecules into target cells to treat diseases. This technology has the implicit to revise the treatment of inherited genetic disorders, cancer and other intractable driseases. ...
Alfa Cytology has announced cancer diagnostic biomarker development services to enhance precision in oncology research. Alfa Cytology, a pioneering biotech firm comprising an interdisciplinary team of scientists, bioinformaticians, and oncologists, has recently introduced its cancer diagnostic biomarker development services to advance personalized cancer treatment strategies. Cancer diagnosis ...
Peptidomimetics are structural analogs of peptides or proteins that mimic their biological activities. They are designed to overcome limitations associated with peptides, such as poor stability and bioavailability by preserving or enhancing their functions. Peptidomimetic development involves the design and synthesis of molecules that mimic three-dimensional structures and functional groups of ...
Antibody drugs, as a breakthrough in biotechnology, are now widely used in the treatment of various diseases, including cancer, autoimmune diseases, and infectious diseases. These drugs are usually precisely designed protein molecules that can specifically bind to targets in the human body, such as specific molecules on pathogens or diseased cells, thereby guiding the attack of the immune system ...
Understanding Clonality Analysis Clonality refers to the origin of a cell population from a single 'parent' or progenitor cell through asexual reproduction or division. This concept is vital in cancer studies as it helps track the development of tumor cells from a single mutated cell. Clonality analysis is thus essential in understanding the evolution and the spread of cancerous cells in a ...
The emergence of chimeric antigen receptor T-cell (CAR-T) therapy has revolutionized the treatment of certain cancers, providing a promising targeted approach to eliminate cancer cells. ...
Due to the importance of many proteins localized in centrosomes in cell movement, such as isomorph CRA and HS actin gamma1, antibodies targeting these proteins have also become powerful tools for treating related diseases. ...
Moreover, RNases play a defensive role against RNA viruses, serving as a frontline mechanism in the cellular immune response. By targeting viral RNA for degradation, these enzymes help prevent the replication and propagation of viral pathogens. ...
The development principle of cancer vaccines usually includes the identification of antigens, vaccine formulation, immune activation, and targeting of cancer cells. ...
In response to the emerging needs in global healthcare, SOPHiA GENETICS has just revealed the New Generation SOPHiA DDM™ Platform, aiming to stay at the forefront of precision medicine and address today the healthcare needs of tomorrow. ...
Omics Analysis for Brain Tumors Similarly, by integrating data from multiple omics layers, researchers can understand the complex biology of tumors better and develop targeted therapies. Most of the omics analysis services for brain tumors provided by biotech companies or professional organizations commonly involve omics technologies, encompassing genomics, ...